KCNJ12 Antibody, Biotin conjugated

Shipped with Ice Packs
In Stock

Description

Introduction to KCNJ12 Antibody, Biotin Conjugated

KCNJ12 Antibody, Biotin conjugated is a specialized immunological reagent designed to detect and bind to the Potassium Inwardly-Rectifying Channel, Subfamily J, Member 12 (KCNJ12), also known as Kir2.2. This antibody utilizes biotin conjugation technology, which enhances detection sensitivity in various applications. The biotin labeling allows the antibody to interact with enzyme-conjugated streptavidin, creating a powerful detection system for experimental and diagnostic applications .

The target protein, KCNJ12, is an integral membrane protein that forms potassium channels characterized by a greater tendency to allow potassium to flow into the cell rather than out, hence the designation "inwardly-rectifying." These channels play critical roles in establishing resting membrane potential and regulating cellular excitability across multiple tissue types. The biotin-conjugated antibody allows researchers to effectively study this important channel protein in various experimental contexts .

Molecular Structure

KCNJ12 Antibody, Biotin conjugated consists of a polyclonal immunoglobulin G (IgG) antibody derived from rabbit, which has been chemically linked to biotin molecules. The antibody specifically targets amino acids 182-433 of the human KCNJ12 protein, a region that forms part of the cytoplasmic domain of this channel protein .

Physical and Chemical Properties

The antibody is typically formulated in a buffer solution containing 0.01M Sodium Phosphate, 0.25M NaCl at pH 7.6, with 5mg/ml Bovine Serum Albumin (BSA) and 0.02% Sodium Azide as preservatives. This formulation maintains antibody stability while preventing microbial contamination during storage .

Table 1: Physical and Chemical Properties of KCNJ12 Antibody, Biotin Conjugated

PropertyDescription
HostRabbit
ClonalityPolyclonal
IsotypeIgG
Target RegionAmino acids 182-433 of KCNJ12
Purification>95%, Protein G purified
ConjugateBiotin
ReactivityHuman, Mouse, Rat
Formulation0.01M Sodium Phosphate, 0.25M NaCl, pH 7.6, 5mg/ml BSA, 0.02% Sodium Azide
Storage ConditionsStore at 4°C for 6 months

Experimental Applications

KCNJ12 Antibody, Biotin conjugated demonstrates versatility across multiple experimental applications. The primary documented use is in Enzyme-Linked Immunosorbent Assay (ELISA), where the biotin conjugation works synergistically with enzyme-conjugated streptavidin to produce detectable signals when the antibody binds to the target KCNJ12 protein .

While ELISA represents the primary validated application, the antibody's format also makes it potentially suitable for immunofluorescence (IF) studies, allowing researchers to visualize the spatial distribution of KCNJ12 channels within cellular contexts. The recommended working dilutions vary by application but generally range from 1:50 to 1:1,000 when used with enzyme-conjugated streptavidin systems .

Research Applications

This biotin-conjugated antibody serves as a valuable tool for investigating the expression, localization, and function of KCNJ12 in both normal physiology and pathological states. It enables researchers to:

  1. Quantify KCNJ12 protein levels in tissue and cell lysates

  2. Examine the subcellular localization of KCNJ12 channels

  3. Study changes in KCNJ12 expression during development or disease progression

  4. Investigate interactions between KCNJ12 and other cellular components

Functional Role in Normal Physiology

KCNJ12 encodes an inwardly rectifying potassium channel that plays critical roles in maintaining normal cellular excitability and potassium balance in blood. These channels are particularly important in excitable tissues such as muscle and nervous system, where they contribute to establishing resting membrane potential and regulating action potential duration .

Recent research has revealed that KCNJ12 participates in muscle development and regeneration processes. Studies have demonstrated that KCNJ12 positively regulates myoblast proliferation while inhibiting differentiation, suggesting its importance in balancing growth and specialization during muscle formation and repair .

Involvement in Pathological Conditions

Disruptions in KCNJ12 function have been implicated in several pathological conditions. Notably, blocking the cellular trafficking of KCNJ12 and the related KCNJ2 to the cell surface has been associated with hyperthyroidism in thyrotoxic periodic paralysis, a condition characterized by episodes of muscle weakness .

Additionally, research has indicated that KCNJ12 may promote cancer cell proliferation and control tumor growth through mechanisms involving increased RelA phosphorylation at S536, activation of transcription factors, and elevated expression of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) targets. These targets include cyclin D1 (CCND1), matrix metalloproteinase 9 (MMP9), and vascular endothelial growth factor (VEGF) .

KCNJ12 in Muscle Development

Research using KCNJ12 antibodies has provided significant insights into the role of this channel protein in muscle biology. In a comprehensive study, researchers demonstrated that KCNJ12 promotes proliferation and inhibits differentiation of bovine primary myoblasts .

When KCNJ12 was overexpressed in bovine primary myoblasts, researchers observed:

  • Enhanced cell viability as measured by CCK-8 assay

  • Increased percentage of EdU-positive cells, indicating higher proliferation rates

  • Altered cell cycle progression with increased percentage of S-phase cells and decreased G1-phase cells

  • Upregulated protein expression of cell cycle promoters CDK2 and CCND1

  • Downregulated expression of cell cycle inhibitor p27

Conversely, inhibition of KCNJ12 produced opposite effects, confirming its regulatory role in myoblast proliferation .

KCNJ12 in Muscle Regeneration

In vivo studies using mouse models of muscle injury have further elucidated the role of the KCNJ12 regulatory network in muscle regeneration. When the upstream regulator circRIMKLB (which influences KCNJ12 expression) was overexpressed in injured muscle tissue, researchers observed:

  • Enhanced muscle injury repair as visualized by histological analysis

  • Upregulated expression of CDK2 and CCND1

  • Decreased expression of p27

These findings suggest that KCNJ12 participates in cell cycle regulation during muscle regeneration following injury, highlighting its potential therapeutic relevance in muscle-related disorders .

Antibody Production

KCNJ12 Antibody, Biotin conjugated is produced using recombinant human KCNJ12 protein (amino acids 182-433) as the immunogen. The antibody is raised in rabbits and undergoes affinity purification using Protein G to achieve >95% purity before biotin conjugation .

The biotin conjugation process attaches biotin molecules to the antibody structure without compromising its antigen-binding capacity. This conjugation enables the antibody to interact with streptavidin-linked detection systems, enhancing its utility in various experimental applications .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Typically, we can ship products within 1-3 business days of receiving your order. Delivery times may vary depending on the purchasing method or location. For specific delivery details, please consult your local distributors.
Synonyms
KCNJ12; IRK2; KCNJN1; ATP-sensitive inward rectifier potassium channel 12; Inward rectifier K(+ channel Kir2.2; IRK-2; Inward rectifier K(+ channel Kir2.2v; Potassium channel, inwardly rectifying subfamily J member 12
Target Names
KCNJ12
Uniprot No.

Target Background

Function
This antibody targets the KCNJ12 gene, which encodes an inward rectifying potassium channel activated by phosphatidylinositol 4,5-bisphosphate. This channel plays a crucial role in regulating the resting membrane potential in electrically excitable cells. It is believed to contribute to the establishment of action potential waveform and excitability in neuronal and muscle tissues. Inward rectifier potassium channels exhibit a preference for potassium influx into the cell rather than efflux. Their voltage dependence is modulated by the concentration of extracellular potassium; as external potassium levels rise, the voltage range for channel opening shifts towards more positive values. The inward rectification is primarily attributed to the blockage of outward current by internal magnesium.
Gene References Into Functions
  1. Cellular electrophysiology studies on mouse Kir2.1 and human Kir2.2 revealed that, in agreement with simulations, the Leu residue enhanced the channel responses to phosphatidylinositol diphosphate (PIP2) by increasing binding affinity and accelerating activation kinetics. Conversely, deactivation kinetics decreased upon PIP2 inhibition. PMID: 26520451
  2. This report is the first to identify the KCNJ12 gene as a causative factor in familial dilated cardiomyopathy in patients. PMID: 28816949
  3. The augmentation of Ca(2+) influx and cytokine release suggests a physiological role for Kir2.2 in TLR4-stimulated monocytes. PMID: 26324774
  4. An unconventional role of the inwardly rectifying potassium channel Kir2.2 as a constitutive activator of RelA in cancer has been identified. PMID: 23269273
  5. Kir2.2 knockdown induces senescence of cancer cells through a mechanism involving reactive oxygen species accumulation. PMID: 20841375
  6. Heteromerization contributes to the phenotype of Andersen syndrome. PMID: 12032359
  7. Molecular cloning of functional KCNJ12 with an arginine residue at position 285 has been reported. PMID: 12417321
  8. Transcripts for Kir2.2 potassium channels are identified in proliferative smooth muscle cells. PMID: 12598232
  9. Data show that the recovery of K(ir)2.2 from inhibition by FCCP requires intracellular components, however, direct depletion of ATP does not replicate the differential inhibitory effect of FCCP. PMID: 19016473

Show More

Hide All

Database Links

HGNC: 6258

OMIM: 602323

KEGG: hsa:3768

STRING: 9606.ENSP00000328150

UniGene: Hs.200629

Protein Families
Inward rectifier-type potassium channel (TC 1.A.2.1) family, KCNJ12 subfamily
Subcellular Location
Membrane; Multi-pass membrane protein. Cell membrane; Multi-pass membrane protein.

Q&A

What is KCNJ12 and what cellular functions does it serve?

KCNJ12 (also known as Kir2.2, IRK2, hIRK, and several other aliases) is an inwardly rectifying potassium channel that can be blocked by divalent cations. This protein is one of multiple inwardly rectifying channels that contribute to the cardiac inward rectifier current (IK1). The gene is located within the Smith-Magenis syndrome region on chromosome 17 . KCNJ12 functions as an ATP-sensitive inward rectifier potassium channel that plays critical roles in maintaining resting membrane potential and regulating action potential duration in excitable cells, particularly in cardiac tissue. The channel's activity is essential for normal cardiac function, as it contributes to the late repolarization phase of the cardiac action potential .

What are the common applications for KCNJ12 antibodies in research?

Based on antibody product information, KCNJ12 antibodies are routinely used in multiple experimental applications including:

ApplicationDescriptionFrequency of Use
Western Blotting (WB)Detecting denatured KCNJ12 protein in cell/tissue lysatesMost common
Immunohistochemistry (IHC-P)Localizing KCNJ12 in fixed tissue sectionsCommon
Immunofluorescence (IF)Visualizing KCNJ12 distribution in fixed cellsCommon
Immunocytochemistry (ICC)Detecting KCNJ12 in cultured cellsCommon
ELISAQuantitative detection of KCNJ12 in solutionCommon
MicroarrayProtein expression profilingLess common

Most KCNJ12 antibodies demonstrate compatibility with multiple applications, allowing researchers to employ various techniques within a single experimental workflow .

How does biotin conjugation improve antibody utility in KCNJ12 research?

Biotin conjugation of KCNJ12 antibodies provides several methodological advantages in research applications. The biotin-streptavidin system offers one of the strongest non-covalent biological interactions known, enhancing detection sensitivity and signal amplification. In ELISA assays specifically designed for KCNJ12 detection, a biotin-conjugated detection antibody binds to captured KCNJ12 proteins, followed by the addition of streptavidin-HRP for signal development .

The amplification effect is particularly valuable when working with low-abundance channel proteins like KCNJ12. Additionally, biotin conjugation allows for methodological flexibility, as the same antibody can be detected using various streptavidin-conjugated reporter systems (HRP, fluorophores, gold particles) without requiring secondary antibodies specific to the host species, reducing background signal in multi-labeling experiments .

What species reactivity should be considered when selecting a KCNJ12 antibody?

Species reactivity is a critical consideration when selecting KCNJ12 antibodies. Based on the available commercial products, researchers should consider the following patterns of reactivity:

Antibody ExampleSpecies ReactivityHostIsotype
Biorbyt orb450660Human, Mouse, RatRabbitIgG
LifeSpan LS-C432497Human, Mouse, Rat, Canine, Guinea Pig, Hamster, Equine, Gibbon, Chimpanzee, MonkeyRabbitIgG
US Biological 037324HumanRabbitIgG
Biorbyt orb148348Human, RatMouseIgG1

When designing experiments involving multiple species or transgenic models, researchers should verify cross-reactivity with the specific KCNJ12 isoform of interest. Sequence homology between species varies across regions of the protein, which may affect epitope recognition . For highly conserved research applications, antibodies with broad cross-reactivity like LifeSpan LS-C432497 may provide more consistent results across species.

What are the typical protein detection methods used with KCNJ12 antibodies?

Detection methods for KCNJ12 using biotin-conjugated antibodies typically include:

  • Sandwich ELISA: A quantitative method where capture antibodies bind KCNJ12, followed by biotin-conjugated detection antibodies. Streptavidin-HRP is then added, followed by substrate solution for colorimetric detection. This method allows for quantitative measurement of KCNJ12 in serum, plasma, cell culture supernatants, tissue homogenates, and other biological fluids .

  • Immunoblotting: Following protein separation by SDS-PAGE and transfer to membranes, biotin-conjugated KCNJ12 antibodies can be applied, followed by streptavidin-HRP and chemiluminescent detection. This approach allows for protein size verification and semi-quantitative analysis .

  • Immunofluorescence/Immunocytochemistry: For cellular localization studies, biotin-conjugated antibodies can be visualized using fluorophore-conjugated streptavidin, enabling subcellular localization analysis of KCNJ12 channels .

How can KCNJ12 antibodies be utilized in protein trafficking studies?

KCNJ12 antibodies can be employed in sophisticated trafficking studies to elucidate channel movement through cellular compartments. Based on research methodologies described in the literature for related potassium channels, several approaches can be applied to KCNJ12:

  • Surface protein biotinylation assays: Cell surface proteins can be labeled with biotin, followed by precipitation with streptavidin and immunoblotting with KCNJ12 antibodies to quantify surface expression.

  • Fluorogen Activating Protein (FAP) tagging: As demonstrated with the related Kir2.1 channel, FAP tags can be engineered to measure surface expression of ion channels in real-time. When combined with KCNJ12 antibodies in co-localization studies, this approach provides dynamic trafficking information .

  • Biochemical fractionation: Cellular components can be separated through differential centrifugation, followed by immunoblotting with KCNJ12 antibodies to track the channel's distribution across membrane compartments. Research on related channels demonstrates how these methods can reveal trafficking regulation by α-arrestins and other sorting proteins .

  • Confocal microscopy with organelle markers: Co-staining with biotin-conjugated KCNJ12 antibodies and markers for the endoplasmic reticulum, Golgi apparatus, endosomes, and plasma membrane allows visualization of the channel's trafficking itinerary .

What considerations should be made for optimizing KCNJ12 antibody performance in different applications?

Optimizing KCNJ12 antibody performance requires careful consideration of several experimental parameters:

ApplicationKey Optimization ParametersConsiderations
Western BlottingProtein extraction methodUse specialized membrane protein extraction buffers with appropriate detergents to solubilize KCNJ12
Blocking reagent5% non-fat milk or BSA in TBS-T; test both to determine optimal background reduction
Antibody concentrationTypical dilutions range from 1:500-1:2000; titrate for optimal signal-to-noise ratio
IHC/ICC/IFFixation methodParaformaldehyde (4%) is typically preferred; avoid methanol which can disrupt membrane protein structure
PermeabilizationUse mild detergents (0.1-0.3% Triton X-100) to preserve channel epitopes
Antigen retrievalTest heat-induced epitope retrieval methods if signal is weak
ELISAPlate coatingOptimize capture antibody concentration (typically 1-10 μg/mL)
Sample dilutionPrepare a dilution series to ensure measurements fall within the linear range
Incubation timeLonger incubation (overnight at 4°C) may improve sensitivity

Signal amplification systems such as tyramide signal amplification can be employed with biotin-conjugated antibodies when studying low-abundance KCNJ12 expression .

How do experimental conditions affect KCNJ12 antibody binding and channel conformation?

KCNJ12 channel conformation and antibody binding can be significantly influenced by experimental conditions:

  • pH sensitivity: As an ion channel, KCNJ12 undergoes conformational changes in response to pH fluctuations. Maintaining physiological pH (7.2-7.4) during experiments is critical for preserving native structure. Flow cytometry and biochemical analyses should include appropriate pH controls .

  • Divalent cations: Since KCNJ12 can be blocked by divalent cations, the presence of Ca²⁺ or Mg²⁺ in buffers may induce conformational changes that affect antibody accessibility to certain epitopes. Experimental buffers should be carefully formulated based on whether open or closed channel conformations are being studied .

  • Detergent selection: When extracting KCNJ12 for immunoprecipitation or Western blotting, detergent choice significantly impacts channel structure preservation. Milder detergents (e.g., digitonin, CHAPS) better maintain quaternary structure compared to stronger detergents (e.g., SDS, Triton X-100) .

  • Temperature: Sample handling temperature affects KCNJ12 stability and trafficking. For tracking surface expression, experiments should be conducted at physiological temperature (37°C) rather than room temperature to maintain normal trafficking kinetics .

What validation techniques should be employed to confirm KCNJ12 antibody specificity?

Rigorous validation of KCNJ12 antibodies is essential for reliable research results. Recommended validation approaches include:

  • Knockout/knockdown controls: Testing antibodies on samples with CRISPR-mediated KCNJ12 knockout or siRNA knockdown is the gold standard for specificity validation.

  • Overexpression systems: Comparing antibody signals between wild-type cells and those overexpressing KCNJ12 confirms detection of the correct protein.

  • Peptide competition assays: Pre-incubating the antibody with the immunizing peptide should abolish specific signals if the antibody is truly specific.

  • Cross-reactivity testing: Since KCNJ12 shares significant homology with other Kir family members, particularly Kir2.1 (KCNJ2), cross-reactivity testing against related channels is essential. This is especially important when studying tissues where multiple Kir channels are co-expressed .

  • Multiple antibody verification: Using two different antibodies targeting distinct KCNJ12 epitopes helps confirm signal specificity when both show concordant results.

  • Mass spectrometry validation: For immunoprecipitation applications, mass spectrometry analysis of precipitated proteins can confirm KCNJ12 identity and detect potential cross-reactive proteins .

How can KCNJ12 antibodies be used to investigate channel regulation by protein-protein interactions?

KCNJ12 antibodies provide valuable tools for studying regulatory protein-protein interactions:

  • Co-immunoprecipitation (Co-IP): Biotin-conjugated KCNJ12 antibodies can be used to isolate channel complexes, followed by immunoblotting for suspected interacting partners. This approach has revealed interactions between related Kir channels and trafficking factors like α-arrestins .

  • Proximity ligation assay (PLA): This technique can detect protein interactions within 40nm distance in situ. Using a KCNJ12 antibody paired with antibodies against suspected interacting proteins generates fluorescent spots only where proteins are in close proximity.

  • FRET/BRET analysis: When studying overexpressed tagged KCNJ12, antibody staining can confirm appropriate expression and localization before energy transfer measurements.

  • Surface plasmon resonance: Purified KCNJ12 can be immobilized using biotin-conjugated antibodies for quantitative interaction studies with regulatory proteins.

  • Trafficking regulation studies: Research on related channels demonstrates that protein interactions with components like α-arrestins and the AP-1 complex regulate channel trafficking. Similar approaches can be applied to study KCNJ12 regulation .

What troubleshooting approaches are recommended for inconsistent KCNJ12 antibody results?

When encountering inconsistent results with KCNJ12 antibodies, systematic troubleshooting approaches include:

  • Sample preparation optimization:

    • Ensure complete solubilization of membrane proteins using appropriate detergents

    • Minimize protein degradation with fresh, cold buffers containing protease inhibitors

    • Verify protein concentration determination methods for membrane-rich samples

  • Antibody validation:

    • Test multiple antibody lots to identify lot-to-lot variability

    • Validate antibody performance using positive and negative controls

    • Consider epitope accessibility in different applications (native vs. denatured conditions)

  • Protocol refinement:

    • Optimize antibody concentration through titration experiments

    • Adjust incubation time and temperature conditions

    • Modify blocking reagents to reduce background (BSA vs. non-fat milk)

    • For fluorescent detection, implement autofluorescence quenching steps

  • Technical considerations:

    • For Western blotting, ensure complete transfer of high-molecular-weight complexes

    • For immunofluorescence, optimize fixation to preserve membrane protein epitopes

    • For ELISA, validate the linear range of detection for accurate quantification

  • Biological variables:

    • Consider potential post-translational modifications affecting epitope recognition

    • Account for channel regulation by experimental conditions (temperature, pH, ionic strength)

How can KCNJ12 antibodies be utilized in electrophysiological studies?

Combining immunological detection with electrophysiological measurements provides powerful insights into KCNJ12 function:

  • Correlation of protein expression with current density: Patch-clamp electrophysiology can measure inward rectifier currents, while immunocytochemistry with biotin-conjugated KCNJ12 antibodies can quantify channel expression in the same cells or tissue sections. This approach helps establish relationships between channel abundance and functional output.

  • Channel subunit composition analysis: In tissues expressing multiple inward rectifier channels, immunoprecipitation with KCNJ12-specific antibodies followed by immunoblotting for other subunits can reveal heteromeric channel composition that may explain unique electrophysiological properties.

  • Subcellular localization and functional zones: High-resolution imaging with KCNJ12 antibodies can map channel distribution to specific cellular domains, correlating with localized electrophysiological recordings to understand compartmentalized channel function.

  • Monitoring trafficking during electrophysiological manipulation: Surface labeling with KCNJ12 antibodies before and after treatments that alter channel function can reveal whether functional changes result from gating modifications or altered surface expression .

What methodologies are recommended for studying KCNJ12 in disease models?

When investigating KCNJ12 in disease contexts, several specialized approaches are recommended:

  • Patient-derived samples:

    • For cardiac arrhythmia studies, immunohistochemistry with biotin-conjugated KCNJ12 antibodies can assess channel distribution in patient cardiac tissue

    • Quantitative ELISA can measure KCNJ12 levels in patient-derived samples for biomarker potential

  • Disease model systems:

    • In heterologous expression systems, trafficking of disease-associated KCNJ12 mutants can be monitored using surface biotinylation and antibody detection

    • For in vivo models, tissue-specific expression patterns can be assessed using immunohistochemistry with KCNJ12 antibodies

  • Therapeutic intervention assessment:

    • KCNJ12 antibodies can monitor changes in channel expression or localization following pharmacological treatments

    • For gene therapy approaches, antibodies distinguish between endogenous and therapeutically expressed channels

  • Comparative studies:

    • When studying KCNJ12 in the context of the Smith-Magenis syndrome region on chromosome 17, antibodies help assess how channel expression correlates with disease phenotypes

How can quantitative analysis of KCNJ12 expression be optimized using biotin-conjugated antibodies?

Quantitative analysis of KCNJ12 requires rigorous methodological approaches:

  • ELISA optimization:

    • For sandwich ELISA, the capture antibody concentration should be optimized (typically 1-10 μg/mL)

    • Standard curves using recombinant KCNJ12 protein ensure accurate quantification

    • Sample dilution series verify measurements within the linear detection range

    • The Human ATP-sensitive inward rectifier potassium channel 12 ELISA Kit provides a validated system for quantitative KCNJ12 detection in serum, plasma, and tissue homogenates

  • Western blot quantification:

    • Include titration controls for signal linearity verification

    • Use housekeeping proteins appropriate for membrane fraction normalization

    • Employ image analysis software with background subtraction capabilities

  • Immunofluorescence quantification:

    • Apply standardized image acquisition parameters

    • Implement automated analysis algorithms to eliminate observer bias

    • Include calibration standards for comparing across experimental batches

  • Flow cytometry:

    • Optimize permeabilization conditions for consistent intracellular access

    • Include fluorescence minus one (FMO) controls for accurate gating

    • Use median fluorescence intensity rather than mean for non-normal distributions

What are the best practices for studying KCNJ12 trafficking in cellular models?

Investigating KCNJ12 trafficking requires sophisticated experimental approaches:

  • Pulse-chase analysis:

    • Surface biotinylation at different time points tracks KCNJ12 internalization rates

    • Temperature blocks (e.g., 15°C) can isolate specific trafficking steps between compartments

  • Compartment-specific markers:

    • Co-localization analysis with markers for ER (calnexin), Golgi (GM130), endosomes (Rab proteins), and lysosomes (LAMP1) maps KCNJ12 trafficking itinerary

    • Quantitative co-localization metrics should be applied for objective analysis

  • Trafficking mutants:

    • Expression of KCNJ12 with mutated trafficking motifs helps identify regulatory sequences

    • Dominant-negative trafficking proteins can probe mechanism specificity

  • Live-cell imaging:

    • When combined with complementary techniques like FAP tagging (demonstrated with related channels), antibody-based methods provide comprehensive trafficking information

    • pH-sensitive fluorophores can distinguish surface from internalized channels

  • Heterologous expression systems:

    • Model systems like yeast have been successfully used to study trafficking of related potassium channels and can be adapted for KCNJ12 studies

    • α-Arrestin-dependent trafficking mechanisms identified in model systems may apply to KCNJ12 regulation

How might emerging antibody technologies enhance KCNJ12 research?

Emerging technologies promise to expand KCNJ12 research capabilities:

  • Single-domain antibodies (nanobodies):

    • Smaller size enables access to sterically hindered epitopes in KCNJ12 complexes

    • Potential for intrabody applications to track KCNJ12 in living cells

    • Enhanced penetration in tissue sections improves detection in thick preparations

  • Recombinant antibody fragments:

    • Fab and scFv formats with site-specific biotin conjugation improve consistency

    • Engineered fragments with enhanced affinity may improve detection of low-abundance KCNJ12

  • Multiplexed detection systems:

    • Mass cytometry (CyTOF) using metal-tagged antibodies enables simultaneous detection of KCNJ12 with dozens of other proteins

    • Antibody-based proximity labeling can identify novel KCNJ12 interacting partners

  • Super-resolution microscopy compatibility:

    • Optimized biotin-conjugated antibodies for STORM, PALM, or STED microscopy can reveal nanoscale KCNJ12 organization at the plasma membrane

    • Single-particle tracking approaches can monitor KCNJ12 dynamics in real-time

What are the current challenges in KCNJ12 antibody-based research?

Despite advances, several challenges remain in KCNJ12 antibody research:

  • Cross-reactivity concerns:

    • High sequence homology between Kir family members (particularly between Kir2.1, Kir2.2, and Kir2.3) creates specificity challenges

    • Limited epitope availability in native channel conformations restricts antibody design options

  • Technical limitations:

    • Low endogenous expression levels in many tissues require sensitive detection methods

    • Quaternary structure preservation during sample preparation remains challenging

    • Membrane protein aggregation during extraction can produce artifacts

  • Validation standards:

    • Inconsistent validation approaches across studies complicate result comparison

    • Limited availability of knockout controls for definitive specificity testing

  • Application gaps:

    • Few antibodies are validated for immunoprecipitation of native KCNJ12 complexes

    • Limited options for detecting specific post-translational modifications

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.